ArcticZymes Technologies - Board/Management Information 2014

Biotec Pharmacon hires Jethro Holter as new Managing Director in ArcticZymes AS

Biotec Pharmacon is pleased to announce that the company has hired Mr.

Jethro Holter (42) as the new Managing Director in its subsidiary

ArcticZymes AS.

Holter is today business development manager in Life Technologies

(Norway) - a part of the global company Thermo Fischer Scientific -

which offers high-quality, innovative life science solutions from

everyday essentials to instruments - for every lab, every application.

In Life Technologies (Norway) Holter is responsible for OEM and

Licensing.

Holter holds a PhD in molecular biology from University of Cardiff.

It has been crucial for the development of ArcticZymes that we get a

leader with a commercial background from the molecular biology industry

on board. At the same time, it has been important for us that the right

candidate has the technological knowledge to understand the trends of

this complicated business.

I am very satisfied that we today can demonstrate that we have found

both, and I welcome Jethro to the team. Going forward, I am really

looking forward to working with him, comments CEO Svein Lien in Biotec

Pharmacon, who has been the acting leader in the last couple of years.

Holter will take on his position 1 January 2015. He resides in Oslo, but

he will spend a lot of time at the ArcticZymes office in Tromsø.

For further information, please contact:

CEO Svein W. F. Lien, +47 922 89 323.

About Biotec Pharmacon ASA:

Biotec Pharmacon ASA is the parent company of Biotec BetaGlucans AS and

ArcticZymes AS. Biotec BetaGlucans develops and manufactures novel

immunomodulating products, and has recently obtained CE-mark for

Woulgan® Biogel containing its proprietary substance SBG®. Woulgan®

Biogel is a primary dressing for one-time use on skin wounds, including

diabetic ulcers, bedsores, leg ulcers, transplantation wounds, post

-surgery wounds, trauma wounds, first- and second-degree burns,

abrasions, and cuts. ArcticZymes develops, produces and sells enzymes of

marine origin used in molecular DNA technologies and diagnostics, growth

markets where rapid technological developments are creating a strong

demand for new and improved enzymes.

AI assistant